Johnson & Johnson Contracts & Agreements

122 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement for Johnson & Johnson €4 Billion Notes Offering (2029–2055)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
NY
2025
Johnson & Johnson Company Order for Issuance of Euro-Denominated Notes (2029–2055)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2025
Johnson & Johnson 2.700% Note Due 2029 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.050% Note Due 2033 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.350% Note Due 2037 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.600% Note Due 2045 Issued Under Indenture to The Bank of New York Mellon Trust Company
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.700% Note Due 2055 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Underwriting Agreement for Johnson & Johnson $5 Billion Notes Offering (2027–2035) with Citigroup, BofA, J.P. Morgan, and Others
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2025
Johnson & Johnson Standard Underwriting Agreement Provisions (Debt) – February 2025
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2025
Johnson & Johnson Company Order for Issuance of Series Notes under Indenture (2025)
Indenture Agreements
Johnson & Johnson
Pharmaceuticals
2025
Johnson & Johnson 4.500% Note Due 2027 (Global Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.550% Note Due 2028 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.700% Note Due 2030 (Global Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.850% Note Due 2032 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 5.000% Note Due 2035 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson Description of Capital Stock and Registered Debt Securities
Johnson & Johnson
Pharmaceuticals
NY
2025
Johnson & Johnson Executive Officer Cash Severance Policy
Severance Agreements
Johnson & Johnson
Pharmaceuticals
2025
Johnson & Johnson Underwriting Agreement for $4 Billion Notes Offering (2024)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2024
Johnson & Johnson Standard Debt Underwriting Agreement Provisions (May 2024)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2024
Johnson & Johnson Underwriting Agreement for €2.5 Billion Notes Offering (2024)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
NY
2024
Johnson & Johnson Order for Issuance of Series Notes under Indenture (May 2024)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2024
Johnson & Johnson 4.800% Note Due 2029 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 4.900% Note Due 2031 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 4.950% Note Due 2034 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 5.250% Note Due 2054 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson Order for Issuance of Euro-Denominated Notes Due 2032, 2036, and 2044
Note Agreements
Johnson & Johnson
Pharmaceuticals
2024
Johnson & Johnson 3.200% Note Due 2032 (Euro) – The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 3.350% Note Due 2036 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 3.550% Note Due 2044 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 2022 Long-Term Incentive Plan Global Restricted Share Unit Award Agreement with John Christian Reed
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson Deferred Compensation Plan for Management and Highly Compensated Employees
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2023
Separation Agreement between Johnson & Johnson and Kenvue Inc. dated May 3, 2023
Separation Agreements
Johnson & Johnson
Pharmaceuticals
DE
2023
Tax Matters Agreement between Johnson & Johnson and Kenvue Inc. (May 3, 2023)
Johnson & Johnson
Pharmaceuticals
DE
2023
Employee Matters Agreement between Johnson & Johnson and Kenvue Inc. (May 3, 2023)
Separation Agreements
Johnson & Johnson
Pharmaceuticals
DE
2023
Intellectual Property Agreement between Johnson & Johnson and Kenvue Inc. (May 3, 2023)
License Agreements
Johnson & Johnson
Pharmaceuticals
DE
2023
Trademark Phase-Out License Agreement between Johnson & Johnson and Johnson & Johnson Consumer Inc. (April 3, 2023)
License Agreements
Johnson & Johnson
Pharmaceuticals
DE
2023
Registration Rights Agreement between Johnson & Johnson and Kenvue Inc. dated May 3, 2023
Registration Rights Agreements
Johnson & Johnson
Pharmaceuticals
DE
2023
Johnson & Johnson 2022 Long-Term Incentive Plan Global Performance Share Unit Award Agreement
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2023
Johnson & Johnson 2022 Long-Term Incentive Plan Global Restricted Share Unit Award Agreement
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2023
Johnson & Johnson 2022 Long-Term Incentive Plan Global Nonqualified Stock Option Award Agreement
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2023
Johnson & Johnson Excess Benefit Plan (2022 Restatement)
Retirement Agreements
Johnson & Johnson
Pharmaceuticals
2023
Contingent Value Rights Agreement between Johnson & Johnson and American Stock Transfer & Trust Company, LLC (December 22, 2022)
Stock Agreements
Johnson & Johnson
Pharmaceuticals
DE
2022
Agreement and Plan of Merger among Johnson & Johnson, Athos Merger Sub, Inc., and Abiomed, Inc. dated October 31, 2022
Merger Agreements
Johnson & Johnson
Pharmaceuticals
DE
2022
Johnson & Johnson Standard Underwriting Agreement Provisions (Debt)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2020
Johnson & Johnson Company Order for Issuance of Series Notes (2025–2060)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2020
Description of Johnson & Johnson Capital Stock and Debt Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Johnson & Johnson
Pharmaceuticals
NY
2020
Johnson & Johnson Executive Incentive Plan (Amended as of November 28, 2018)
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2019
Johnson & Johnson Transition and Separation Agreement with Sandra Peterson (June 20, 2018)
Separation Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2018
Johnson & Johnson 2012 Long-Term Incentive Plan Global Nonqualified Stock Option Award Agreement
Warrant Agreements
Johnson & Johnson
Pharmaceuticals
CA
2018
Johnson & Johnson 2012 Long-Term Incentive Plan Global Restricted Share Unit Award Agreement
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
CA
2018
Johnson & Johnson 2012 Long-Term Incentive Plan Global Performance Share Unit Award Agreement
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
CA
2018
Second Supplemental Indenture between Johnson & Johnson and The Bank of New York Mellon Trust Company, N.A. (November 9, 2017)
Indenture Agreements
Johnson & Johnson
Pharmaceuticals
NY
2017
Johnson & Johnson Order for Issuance of Series Notes under Indenture (November 2017)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2017
Johnson & Johnson Standard Underwriting Agreement Provisions (Debt)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2017
Johnson & Johnson Company Order for Issuance of Notes under Indenture (February 2017)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2017
Transaction Agreement among Cilag Holding AG, Janssen Holding GmbH, Actelion Ltd, and Johnson & Johnson (2017)
Merger Agreements
Johnson & Johnson
Pharmaceuticals
NY
2017
Underwriting Agreement between Johnson & Johnson and Multiple Underwriters for Euro-Denominated Notes (May 2016)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
NY
2016
Johnson & Johnson 0.650% Note Due 2024 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 1.150% Note Due 2028 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 1.650% Note Due 2035 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Second Amendment to the Severance Pay Plan of Johnson & Johnson and U.S. Affiliated Companies
Severance Agreements
Johnson & Johnson
Pharmaceuticals
2016
First Amendment to Severance Pay Plan of Johnson & Johnson and U.S. Affiliated Companies
Severance Agreements
Johnson & Johnson
Pharmaceuticals
2015
Johnson & Johnson Executive Life Insurance Program Closure Notice to MetLife
Termination Agreements
Johnson & Johnson
Pharmaceuticals
2015
Amendment to the Excess Benefit Plan of Johnson & Johnson and Affiliates (Effective January 1, 2015)
Retirement Agreements
Johnson & Johnson
Pharmaceuticals
2015
Johnson & Johnson and U.S. Affiliated Companies Severance Pay Plan Amendment and Restatement (2014)
Severance Agreements
Johnson & Johnson
Pharmaceuticals
2014
Johnson & Johnson Executive Income Deferral Plan (Amended and Restated Effective January 1, 2010)
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson Offer Letter for Paul Stoffels as Worldwide Chairman, Pharmaceuticals Group and Chief Scientific Officer
Employment Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson Restricted Share Unit Certificate under 2012 Long-Term Incentive Plan
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson 2012 Long-Term Incentive Plan Performance Share Unit Certificate
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2012
Johnson & Johnson 2000 Stock Option Plan (as Amended)
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson Amended and Restated Deferred Fee Plan for Directors (as of January 17, 2012)
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2012
Johnson & Johnson 2012 Compensation Arrangements for Named Executive Officers and Directors
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson 2005 Long-Term Incentive Plan Performance Share Unit Certificate
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2012
Johnson & Johnson Non-Employee Director Compensation Arrangements Effective January 1, 2012
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2011
Agreement and Plan of Merger among Johnson & Johnson, Samson Acquisition Corp., and Synthes, Inc. (April 26, 2011)
Merger Agreements
Johnson & Johnson
Pharmaceuticals
DE
2011
Voting Agreement between Johnson & Johnson and Wyss Shareholders Regarding Synthes, Inc. Merger
Voting Agreements
Johnson & Johnson
Pharmaceuticals
DE
2011
Johnson & Johnson 2011 Executive and Director Compensation Arrangements
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2011
Johnson & Johnson Non-Employee Director Compensation Arrangements Effective January 1, 2011
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2010
Johnson & Johnson 2010 Executive and Director Compensation Arrangements
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2010
Johnson & Johnson 2009 Certificates of Long-Term Performance Plan
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2009
Amendment to Johnson & Johnson Certificate of Extra Compensation Plan (Now Certificate of Long-Term Compensation Plan)
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2009
Johnson & Johnson Amendments to Deferred Fee Plan for Directors (Section 409A Compliance)
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2009
Amendments to Executive Income Deferral Plan Effective January 1, 2009
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2009
Amendment to Johnson & Johnson Excess Savings Plan (409A Compliance Addendum)
Retirement Agreements
Johnson & Johnson
Pharmaceuticals
2009
Amendment to Excess Benefit Plan of Johnson & Johnson and Affiliated Companies (409A Compliance)
Retirement Agreements
Johnson & Johnson
Pharmaceuticals
2009
Johnson & Johnson 2009 Executive and Director Compensation Arrangements Summary
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2009
Severance Agreement between Johnson & Johnson and Alex Gorsky (2009)
Severance Agreements
Johnson & Johnson
Pharmaceuticals
2009
Johnson & Johnson 2008 Executive and Director Compensation Arrangements Summary
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2008
Johnson & Johnson 2007 Executive and Director Compensation Arrangements Summary
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2007
Summary of Employment Arrangements for Michael J. Dormer with Johnson & Johnson
Employment Agreements
Johnson & Johnson
Pharmaceuticals
2006
Johnson & Johnson 2006 Executive and Director Compensation Arrangements Summary
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2006
Amendment No. 1 to Amended and Restated Agreement and Plan of Merger among Johnson & Johnson, Shelby Merger Sub, Inc., and Guidant Corporation
Merger Agreements
Johnson & Johnson
Pharmaceuticals
2006
Amended and Restated Agreement and Plan of Merger among Johnson & Johnson, Shelby Merger Sub, Inc., and Guidant Corporation (November 14, 2005)
Merger Agreements
Johnson & Johnson
Pharmaceuticals
IN
2005
Settlement Agreement between Guidant Corporation and Johnson & Johnson (November 14, 2005)
Settlement Agreements
Johnson & Johnson
Pharmaceuticals
2005
Johnson & Johnson Deferred Fee Plan for Directors (Amended as of February 14, 2005)
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2005
Summary of Compensation Arrangements for Named Executive Officers and Directors of [Company Name]
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
2005
Agreement and Plan of Merger among Johnson & Johnson, Shelby Merger Sub, Inc., and Guidant Corporation (December 15, 2004)
Merger Agreements
Johnson & Johnson
Pharmaceuticals
IN
2004
Johnson & Johnson and Guidant Corporation Change in Control Severance Plan Modification and Retention Bonus Agreement with Employee
Change of Control Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2004
Johnson & Johnson Certificate of Extra Compensation Plan for Employees
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2004
Johnson & Johnson Executive Income Deferral Plan (As Amended)
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2004
Johnson & Johnson 2000 Stock Option Plan (As Amended February 10, 2003)
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2003
Johnson & Johnson Deferred Fee Plan for Directors (Amended as of December 4, 2002)
Compensation Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2003
Johnson & Johnson Executive Income Deferral Plan (Amended as of December 4, 2002)
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2003
Post-Employment Letter Agreement between Johnson & Johnson and Ralph S. Larsen (June 24, 2002)
Separation Agreements
Johnson & Johnson
Pharmaceuticals
2003
Consulting Agreement between Judah Folkman, M.D. and Johnson & Johnson (2003)
Consulting Agreements
Johnson & Johnson
Pharmaceuticals
2003
Johnson & Johnson Certificate of Extra Compensation Plan (Deferred Compensation Plan)
Bonus & Incentive Agreements
Johnson & Johnson
Pharmaceuticals
2002
Johnson & Johnson Company Order for Issuance of Euro-Denominated Notes (2016)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2016
Johnson & Johnson 0.250% Note Due 2022 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson Company Order for Issuance of Notes under 1987 Indenture
Note Agreements
Johnson & Johnson
Pharmaceuticals
2016
Johnson & Johnson Company Order for Issuance of Notes under 1987 Indenture (2014)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2014
Johnson & Johnson Order for Issuance of Notes under 1987 Indenture (2013)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2013
Johnson & Johnson Floating Rate Note Due 20XX (Form of Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2013
Accelerated Share Repurchase Agreement between Goldman, Sachs & Co. and Janssen Pharmaceutical
Repurchase Agreements
Johnson & Johnson
Pharmaceuticals
NY
2012
Accelerated Share Repurchase Agreement between JPMorgan Chase Bank and Janssen Pharmaceutical (June 2012)
Repurchase Agreements
Johnson & Johnson
Pharmaceuticals
NY
2012
Johnson & Johnson Guarantee Agreement in Favor of Goldman, Sachs & Co. for Janssen Pharmaceutical Accelerated Share Repurchase
Guaranty Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson Guarantee Agreement for Accelerated Share Repurchase with JPMorgan Chase Bank
Guaranty Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson 2012 Stock Option Certificate for Employees
Stock Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson Stock Option Certificate under 2005 Long-Term Incentive Plan
Warrant Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson Restricted Share Unit Certificate under 2005 Long-Term Incentive Plan
Equity Distribution Agreements
Johnson & Johnson
Pharmaceuticals
2012
Johnson & Johnson Company Order for Issuance of Notes (May 2011)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2011
Johnson & Johnson Floating Rate Note Due 20[•] (Form of Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2011
Johnson & Johnson Company Order Establishing Terms of 2.95% and 4.50% Notes Due 2020 and 2040
Note Agreements
Johnson & Johnson
Pharmaceuticals
2010